TB Prevention in the HIV-infected Patient: Screening, Testing, and Treatment of Latent TB Infection

This online course, which includes slides, audio narration, and interactive questions, provides information on how to screen, test, and treat human immunodeficiency virus (HIV)-infected patients for latent tuberculosis infection (LTBI). TB and HIV experts from the Western Region wrote and presented the case-based lessons in this course. The lessons can be taken separately or in any order. Each lesson is 20 minutes or less in length.

Target Audience

This course is designed for clinicians working with patients who are coinfected with HIV and LTBI or patients who are at risk of coinfection with HIV and LTBI.

Introduction:

Two Diseases, One Patient
Presenter: L. Masae Kawamura, MD
Estimated Time: 10 minutes

Module 1:
Screening and Testing for Latent Tuberculosis Infection in HIV-Infected Persons

Lesson 1: Selecting Screening Candidates and Methods
Presenter: Annie Luetkemeyer, MD
Estimated Time: 15 minutes

Lesson 2: Interpreting Test Results
Presenter: Annie Luetkemeyer, MD
Estimated Time: 15 minutes

Module 2:
Treatment for Latent TB Infection in HIV-Infected Persons

Lesson 3: Understanding TB-HIV Drug-Drug Interactions
Presenter: William J. Burman, MD
Estimated Time: 20 minutes

Lesson 4: Deciding When to Treat and Selecting the Regimen
Presenter: Randall Reves, MD, MSc, and Robert W. Belknap, MD
Estimated Time: 15 minutes

Lesson 5: Recognizing and Managing Hepatotoxicity During LTBI Treatment
Presenter: Robert W. Belknap, MD
Estimated Time: 10 minutes

Continuing Education Credits
Note: CITC is no longer offering CME or CNE credits for online courses

Problems with Audio?
If you experience difficulties with the audio, please consult the technical requirements section.

If you need further assistance, please contact us .

Please note:  This online course contains information about the treatment of latent tuberculosis infection (LTBI). It was produced prior to the release of updated guidelines from the CDC in February 2020.  For the most current guidance available regarding LTBI treatment, please see: Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020

Date of Release
December 2011.